全文获取类型
收费全文 | 238248篇 |
免费 | 21909篇 |
国内免费 | 9199篇 |
专业分类
耳鼻咽喉 | 1362篇 |
儿科学 | 5458篇 |
妇产科学 | 3226篇 |
基础医学 | 44507篇 |
口腔科学 | 4189篇 |
临床医学 | 15595篇 |
内科学 | 45033篇 |
皮肤病学 | 3841篇 |
神经病学 | 18923篇 |
特种医学 | 4559篇 |
外国民族医学 | 59篇 |
外科学 | 17609篇 |
综合类 | 28806篇 |
现状与发展 | 35篇 |
预防医学 | 11072篇 |
眼科学 | 3126篇 |
药学 | 31016篇 |
25篇 | |
中国医学 | 8113篇 |
肿瘤学 | 22802篇 |
出版年
2024年 | 377篇 |
2023年 | 3252篇 |
2022年 | 4531篇 |
2021年 | 8976篇 |
2020年 | 7733篇 |
2019年 | 9314篇 |
2018年 | 8942篇 |
2017年 | 8690篇 |
2016年 | 8539篇 |
2015年 | 10135篇 |
2014年 | 14460篇 |
2013年 | 16341篇 |
2012年 | 14509篇 |
2011年 | 17101篇 |
2010年 | 14238篇 |
2009年 | 13583篇 |
2008年 | 13009篇 |
2007年 | 12012篇 |
2006年 | 10871篇 |
2005年 | 9353篇 |
2004年 | 8159篇 |
2003年 | 7029篇 |
2002年 | 5526篇 |
2001年 | 4869篇 |
2000年 | 4048篇 |
1999年 | 3676篇 |
1998年 | 3181篇 |
1997年 | 2997篇 |
1996年 | 2512篇 |
1995年 | 2221篇 |
1994年 | 1945篇 |
1993年 | 1593篇 |
1992年 | 1358篇 |
1991年 | 1169篇 |
1990年 | 950篇 |
1989年 | 814篇 |
1988年 | 701篇 |
1987年 | 580篇 |
1986年 | 572篇 |
1985年 | 1255篇 |
1984年 | 1367篇 |
1983年 | 999篇 |
1982年 | 1054篇 |
1981年 | 889篇 |
1980年 | 779篇 |
1979年 | 678篇 |
1978年 | 541篇 |
1977年 | 425篇 |
1976年 | 446篇 |
1975年 | 381篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
62.
目的:克隆人肠道病毒71型(EV71)及柯萨奇病毒A组16型(CA16)的VP1蛋白编码基因,构建相应真核表达质粒在体外进行重组表达,检测其细胞内定位,为EV71及CA16的疫苗研究提供基础。方法:通过PCR扩增分别获取EV71及CA16的VP1编码序列,插入pcFlag载体,分别构建EV71及CA16 VP1与FLAG标签融合的真核表达质粒;瞬时转染人胚肾293T细胞及横纹肌肉瘤RD细胞,Western blot法检测融合蛋白的表达,免疫荧光检测融合蛋白的细胞内定位情况。结果:测序表明两种来源VP1蛋白的重组表达质粒构建正确;分别转染两种不同的细胞后,均可通过Western blot检测到相应蛋白表达;免疫荧光检测显示两种毒株的VP1均表达在细胞质中。结论:外源融合表达EV71或CA16 VP1蛋白的真核表达质粒构建成功;所构建质粒分别转染细胞后,均可在细胞质内检测到VP1融合蛋白的表达。 相似文献
63.
64.
65.
Xue Wen Ping An Hexuan Li Zijian Zhou Yimin Sun Jian Wang Lixiang Ma Boxun Lu 《神经科学通报》2020,36(12):1414
Expansions of trinucleotide or hexanucleotide repeats lead to several neurodegenerative disorders, including Huntington disease [caused by expanded CAG repeats (CAGr) in the HTT gene], and amyotrophic lateral sclerosis [ALS, possibly caused by expanded GGGGCC repeats (G4C2r) in the C9ORF72 gene], of which the molecular mechanisms remain unclear. Here, we demonstrated that lowering the Drosophila homologue of tau protein (dtau) significantly rescued in vivo neurodegeneration, motor performance impairments, and the shortened life-span in Drosophila expressing expanded CAGr or expanded G4C2r. Expression of human tau (htau4R) restored the disease-related phenotypes that had been mitigated by the loss of dtau, suggesting an evolutionarily-conserved role of tau in neurodegeneration. We further revealed that G4C2r expression increased tau accumulation by inhibiting autophagosome–lysosome fusion, possibly due to lowering the level of BAG3, a regulator of autophagy and tau. Taken together, our results reveal a novel mechanism by which expanded G4C2r causes neurodegeneration via an evolutionarily-conserved mechanism. Our findings provide novel autophagy-related mechanistic insights into C9ORF72-ALS and possible entry points to disease treatment.Electronic supplementary materialThe online version of this article (10.1007/s12264-020-00518-2) contains supplementary material, which is available to authorized users. 相似文献
66.
目的:探讨维生素D对多囊卵巢综合征(PCOS)患者胰岛素抵抗(IR)的影响及其机制研究.方法:选取自2013年2月~2014年2月在该院就诊的48例PCOS患者作为PCOS组,另选30例健康育龄期妇女作为对照组,测量研究者身高、体质量参数,计算体质指数(BMI),采用全自动生化分析仪葡萄糖氧化酶检测空腹血糖浓度(FBG)、化学发光法检测血清空腹胰岛素(FI)及胰岛素样生长因子-1(IGF-1)水平、ELISA方法测定血清25-(OH)D3浓度,计算稳态胰岛素评价指数(HOMA-IR)用于评价胰岛素抵抗性,量化胰岛素敏感指数(QUICKI)用于评价胰岛素敏感度,并分析FI、HOMA-IR、QUICKI及IGF-1与血清25-(OH)D3浓度的相关性.结果:PCOS组BMI及FBG与对照组相比,差异无统计学差异(P>0.05),而FI、HOMA-IR、QUICKI、25-(OH) D3及IGF-1与对照组比较,差异均有统计学差异(P<0.05);并且PCOS组FI和HOMA-IR与血清25-(OH)D3浓度呈显著负相关,差异有统计学意义(P<0.05),QUICKI和IGF-1水平与血清25-(OH)D3浓度呈显著正相关,差异有统计学意义(P<0.05).结论:PCOS患者IR可能与血清中维生素D缺乏有关,而IGF-1分泌减少又可能是导致PCOS患者维生素D缺乏的重要原因. 相似文献
67.
Autoimmune thyroid diseases (AITD) and Type 1 diabetes (T1D) frequently occur in the same individual pointing to a strong shared genetic susceptibility. Indeed, the co-occurrence of T1D and AITD in the same individual is classified as a variant of the autoimmune polyglandular syndrome type 3 (designated APS3v). Our aim was to identify new genes and mechanisms causing the co-occurrence of T1D + AITD (APS3v) in the same individual using a genome-wide approach. For our discovery set we analyzed 346 Caucasian APS3v patients and 727 gender and ethnicity matched healthy controls. Genotyping was performed using the Illumina Human660W-Quad.v1. The replication set included 185 APS3v patients and 340 controls. Association analyses were performed using the PLINK program, and pathway analyses were performed using the MAGENTA software. We identified multiple signals within the HLA region and conditioning studies suggested that a few of them contributed independently to the strong association of the HLA locus with APS3v. Outside the HLA region, variants in GPR103, a gene not suggested by previous studies of APS3v, T1D, or AITD, showed genome-wide significance (p < 5 × 10−8). In addition, a locus on 1p13 containing the PTPN22 gene showed genome-wide significant associations. Pathway analysis demonstrated that cell cycle, B-cell development, CD40, and CTLA-4 signaling were the major pathways contributing to the pathogenesis of APS3v. These findings suggest that complex mechanisms involving T-cell and B-cell pathways are involved in the strong genetic association between AITD and T1D. 相似文献
68.
《Mayo Clinic proceedings. Mayo Clinic》2019,94(7):1321-1329
Immune checkpoint inhibitors are molecules that increase the endogenous immune response against tumors. They have revolutionized the field of oncology. Since their initial approval for the treatment of advanced melanoma, their use has expanded to the treatment of several other advanced cancers. Unfortunately, immune checkpoint inhibitors have also been associated with the emergence of a new subset of autoimmune-like toxicities, known as immune-related adverse events. These toxicities differ depending on the agent, malignancy, and individual susceptibilities. Although the skin and colon are most commonly involved, any organ may be affected, including the liver, lungs, kidneys, and heart. Most of these toxicities are diagnosed by excluding other secondary infectious or inflammatory causes. Corticosteroids are commonly used for treatment of moderate and severe immune-related adverse events, although additional immunosuppressive therapy may occasionally be required. The occurrence of immune-related toxicities may require discontinuation of immunotherapy, depending on the specific toxicity and its severity. In this article, we provide a focused review to familiarize practicing clinicians with this important topic given that the use of immune checkpoint inhibitors continues to increase. 相似文献
69.
70.
Khaled Adil Marija Popovic Fabio L. Cury Sergio L. Faria Marie Duclos Luis Souhami 《Practical radiation oncology》2019,9(1):24-28